Linagliptin and Baclofen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Linagliptin (linagliptin) and Baclofen (baclofen). Common drug interactions include radiculopathy among females and hypovolaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Linagliptin and Baclofen. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.
What is Linagliptin?
Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.
What is Baclofen?
Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.
75 people who take Linagliptin and Baclofen together, and have interactions are studied.

What are the common drug interactions of Linagliptin and Baclofen, by gender? *:
female:
- Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
- Rash
- Restlessness (not able to rest)
- Skin disorder (skin disease)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Spinal compression fracture (fracture due to spinal compression on bone)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Thyroid disorder (thyroid diseases)
- Thyroid neoplasm (tumour of thyroid)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
male:
- Hypovolaemia (a decreased volume of circulating blood in the body)
- Chronic kidney disease
- Gait disturbance
- Gangrene (body tissue dies)
- Gastritis (inflammation of stomach)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Lactic acidosis (low ph in body tissues)
- Loss of consciousness
- Lower respiratory tract infection
- Oesophagitis (inflammation of oesophagus)
What are the common drug interactions of Linagliptin and Baclofen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Asthenia (weakness)
- Constipation
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Dehydration (dryness resulting from the removal of water)
- Disability
- Fatigue (feeling of tiredness)
- Feeling hot
- Influenza like illness
- Migraine (headache)
- Nausea (feeling of having an urge to vomit)
40-49:
- Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Wound dehiscence (a surgical incision reopens either internally or externally)
- Oropharyngeal pain
- Retching (strong involuntary effort to vomit)
- Sensation of foreign body
- Throat irritation
50-59:
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
- Skin infection
- Spinal pain (pain in spine)
- Stress
- Weight decreased
- Acute left ventricular failure (heart attack)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Cardiac failure
- Cardiac failure congestive
60+:
- Abdominal pain upper
- Cardiac failure
- Neoplasm skin (skin tumour)
- Vulvovaginal mycotic infection (vulvovaginal fungal infection)
- Drug ineffective
- Blood pressure increased
- Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
- Pneumonia
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Cardiomegaly (increased size of heart than normal)
What are the existing conditions these people have? *
- Diabetes: 42 people, 56.00%
- Multiple Myeloma (cancer of the plasma cells): 40 people, 53.33%
- Blood Glucose Increased: 37 people, 49.33%
- High Blood Pressure: 9 people, 12.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 10.67%
- High Blood Cholesterol: 6 people, 8.00%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 8.00%
- Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 4 people, 5.33%
- Constipation: 4 people, 5.33%
* Approximation only. Some reports may have incomplete information.
Do you take Linagliptin and Baclofen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Linagliptin (8,112 reports)
- Baclofen (108,662 reports)
Browse all drug interactions of Linagliptin and Baclofen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Linagliptin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Baclofen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Linagliptin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Baclofen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on linagliptin and baclofen (the active ingredients of Linagliptin and Baclofen, respectively), and Linagliptin and Baclofen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lexapro cause Premature Menopause? - a second ago
- Could Se cause Mouth Ulcers? - 21 seconds ago
- Drug interactions of Avastin and Exidine - 23 seconds ago
- Could Levothyroxine Sodium cause Muscle Rigidity? - 23 seconds ago
- Could Levothyroxine Sodium cause Nearsightedness? - 24 seconds ago
- Could Depo-Medrol cause Insomnia? - 28 seconds ago
- Could Levothyroxine Sodium cause Glomerular Filtration Rate Abnormal? - 28 seconds ago
- Dilaudid vs. Diclofenac Potassium, side effect and effectiveness comparison - 28 seconds ago
- Could Glivec cause Osteoporosis? - 29 seconds ago
- Drug interactions of Fosamax and Docetaxel - 31 seconds ago